Cargando…

Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?

BACKGROUND: Prevention of chronic pain relies on accurate detection of at-risk patients. Screening tools have been validated mainly in (sub) acute spinal pain and the need of more generic tools is high. We assessed the validity of the French version of the short Örebro Musculoskeletal Pain Screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Korogod, Natalya, Steyaert, Arnaud, Nonclercq, Olivier, Opsommer, Emmanuelle, Berquin, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976369/
https://www.ncbi.nlm.nih.gov/pubmed/35365109
http://dx.doi.org/10.1186/s12891-021-04944-9
_version_ 1784680552071168000
author Korogod, Natalya
Steyaert, Arnaud
Nonclercq, Olivier
Opsommer, Emmanuelle
Berquin, Anne
author_facet Korogod, Natalya
Steyaert, Arnaud
Nonclercq, Olivier
Opsommer, Emmanuelle
Berquin, Anne
author_sort Korogod, Natalya
collection PubMed
description BACKGROUND: Prevention of chronic pain relies on accurate detection of at-risk patients. Screening tools have been validated mainly in (sub) acute spinal pain and the need of more generic tools is high. We assessed the validity of the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ) in patients with a large range of pain duration and localization. METHODS: First, we re-analyzed data from a 6-month longitudinal study of 73 patients with (sub) acute spinal pain consulting in secondary line settings. Secondly, we performed a new 12-month longitudinal study of 542 primary care patients with (sub) acute and chronic pain in different localizations (spinal, limbs, “non-musculoskeletal”). The area under the receiver operating characteristic curve and cutoff scores were computed and compared for different subpopulations and ÖMPSQ subscores. RESULTS: Data from patients suffering from (sub) acute and chronic spinal pain consulting in both primary and secondary care settings confirmed the validity of the short French ÖMPSQ version and its subsets. In the primary care cohort, the performance of the questionnaire and its psychosocial subscore was variable but at least “fair” in most populations ((sub) acute and chronic, spinal and limb pain). Cutoff scores showed quite large variability depending on the outcome and the subpopulation considered. CONCLUSIONS: These results confirm the usefulness of the short French ÖMPSQ for prediction of the evolution of (sub) acute and chronic patients with spinal and limb pain, whatever its duration. However, increasing population heterogeneity results in slightly worse predictive performance and largely variable cutoff scores. Consequently, it might be difficult to choose universal cutoff scores and other criteria, such as patients’ values and the available resources for patient management, should be taken into account. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-021-04944-9.
format Online
Article
Text
id pubmed-8976369
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89763692022-04-03 Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain? Korogod, Natalya Steyaert, Arnaud Nonclercq, Olivier Opsommer, Emmanuelle Berquin, Anne BMC Musculoskelet Disord Research BACKGROUND: Prevention of chronic pain relies on accurate detection of at-risk patients. Screening tools have been validated mainly in (sub) acute spinal pain and the need of more generic tools is high. We assessed the validity of the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ) in patients with a large range of pain duration and localization. METHODS: First, we re-analyzed data from a 6-month longitudinal study of 73 patients with (sub) acute spinal pain consulting in secondary line settings. Secondly, we performed a new 12-month longitudinal study of 542 primary care patients with (sub) acute and chronic pain in different localizations (spinal, limbs, “non-musculoskeletal”). The area under the receiver operating characteristic curve and cutoff scores were computed and compared for different subpopulations and ÖMPSQ subscores. RESULTS: Data from patients suffering from (sub) acute and chronic spinal pain consulting in both primary and secondary care settings confirmed the validity of the short French ÖMPSQ version and its subsets. In the primary care cohort, the performance of the questionnaire and its psychosocial subscore was variable but at least “fair” in most populations ((sub) acute and chronic, spinal and limb pain). Cutoff scores showed quite large variability depending on the outcome and the subpopulation considered. CONCLUSIONS: These results confirm the usefulness of the short French ÖMPSQ for prediction of the evolution of (sub) acute and chronic patients with spinal and limb pain, whatever its duration. However, increasing population heterogeneity results in slightly worse predictive performance and largely variable cutoff scores. Consequently, it might be difficult to choose universal cutoff scores and other criteria, such as patients’ values and the available resources for patient management, should be taken into account. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-021-04944-9. BioMed Central 2022-04-01 /pmc/articles/PMC8976369/ /pubmed/35365109 http://dx.doi.org/10.1186/s12891-021-04944-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Korogod, Natalya
Steyaert, Arnaud
Nonclercq, Olivier
Opsommer, Emmanuelle
Berquin, Anne
Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
title Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
title_full Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
title_fullStr Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
title_full_unstemmed Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
title_short Can the French version of the short Örebro Musculoskeletal Pain Screening Questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
title_sort can the french version of the short örebro musculoskeletal pain screening questionnaire or its subsets predict the evolution of patients with acute, (sub) acute and chronic pain?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976369/
https://www.ncbi.nlm.nih.gov/pubmed/35365109
http://dx.doi.org/10.1186/s12891-021-04944-9
work_keys_str_mv AT korogodnatalya canthefrenchversionoftheshortorebromusculoskeletalpainscreeningquestionnaireoritssubsetspredicttheevolutionofpatientswithacutesubacuteandchronicpain
AT steyaertarnaud canthefrenchversionoftheshortorebromusculoskeletalpainscreeningquestionnaireoritssubsetspredicttheevolutionofpatientswithacutesubacuteandchronicpain
AT nonclercqolivier canthefrenchversionoftheshortorebromusculoskeletalpainscreeningquestionnaireoritssubsetspredicttheevolutionofpatientswithacutesubacuteandchronicpain
AT opsommeremmanuelle canthefrenchversionoftheshortorebromusculoskeletalpainscreeningquestionnaireoritssubsetspredicttheevolutionofpatientswithacutesubacuteandchronicpain
AT berquinanne canthefrenchversionoftheshortorebromusculoskeletalpainscreeningquestionnaireoritssubsetspredicttheevolutionofpatientswithacutesubacuteandchronicpain